Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis.
Cardiac surgery
Cardiopulmonary bypass
Thyroid hormone
Triiodothyronine
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
26 Mar 2024
26 Mar 2024
Historique:
received:
12
01
2024
accepted:
29
02
2024
medline:
26
3
2024
pubmed:
26
3
2024
entrez:
26
3
2024
Statut:
aheadofprint
Résumé
Specific pediatric populations have exhibited disparate responses to triiodothyronine (T3) repletion during and after cardiopulmonary bypass (CPB). Objective: To determine if T3 supplementation improves outcomes in children undergoing CPB. We searched randomized controlled trials (RCT) evaluating T3 supplementation in children aged 0-3 years undergoing CPB between 1/1/2000 and 1/31/2022. We calculated Hazard ratios (HR) for time to extubation (TTE), ICU length of stay (LOS), and hospital LOS. 5 RCTs met inclusion criteria with available patient-level data. Two were performed in United States (US) and 3 in Indonesia with 767 total subjects (range 29- 220). Median (IQR) age 4.1 (1.6, 8.0) months; female 43%; RACHS-1 scores: 1-1%; 2-55%; 3-27%; 4-13%; 5-0.1%; 6-3.9%; 54% of subjects in US vs 46% in Indonesia. Baseline TSH and T3 were lower in Indonesia (p < 0.001). No significant difference occurred in TTE between treatment groups overall [HR 1.09 (CI, 0.94-1.26)]. TTE numerically favored T3-treated patients aged 1-5 months [HR 1.24 (CI, 0.97-1.60)]. TTE HR for the Indonesian T3 group was 1.31 (CI, 1.04-1.65) vs. 0.95 (CI, 0.78-1.15) in US. The ICU LOS HR for the Indonesian T3 group was 1.19 vs. 0.89 in US (p = 0.046). There was a significant T3 effect on hospital LOS [HR 1.30 (CI, 1.01-1.67)] in Indonesia but not in US [HR 0.99 (CI, 0.78-1.23)]. T3 supplementation in children undergoing CPB is simple, inexpensive, and safe, showing benefit in resource-limited settings. Differences in effects between settings likely relate to depression in baseline thyroid function often associated with malnutrition.
Identifiants
pubmed: 38530419
doi: 10.1007/s00246-024-03465-1
pii: 10.1007/s00246-024-03465-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Bettendorf M, Schmidt KG, Tiefenbacher U et al (1997) Transient Secondary Hypothyroidism in Children after Cardiac Surgery. Pediatr Res 41:375–379. https://doi.org/10.1203/00006450-199703000-000122
doi: 10.1203/00006450-199703000-000122
Klemperer JD, Klein I, Gomez M et al (1995) Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery. New Engl J Medicine 333:1522–1527. https://doi.org/10.1056/nejm1995120733323023
doi: 10.1056/nejm1995120733323023
Klemperer JD, Klein IL, Ojama K et al (1996) Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 61:1323–1329. https://doi.org/10.1016/0003-4975(96)00102-64
doi: 10.1016/0003-4975(96)00102-64
Mullis-Jansson SL, Argenziano M, Corwin S et al (1999) A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117:1128–1134. https://doi.org/10.1016/s0022-5223(99)70249-75
doi: 10.1016/s0022-5223(99)70249-75
Files MD, Kajimoto M, Priddy CMO et al (2014) Triiodothyronine Facilitates Weaning From Extracorporeal Membrane Oxygenation by Improved Mitochondrial Substrate Utilization. J Am Heart Assoc 3:e000680. https://doi.org/10.1161/jaha.113.0006806
doi: 10.1161/jaha.113.0006806
Olson AK, Bouchard B, Ning X-H et al (2012) Triiodothyronine increases myocardial function and pyruvate entry into the citric acid cycle after reperfusion in a model of infant cardiopulmonary bypass. Am J Physiol-heart C 302:H1086–H1093. https://doi.org/10.1152/ajpheart.00959.20117
doi: 10.1152/ajpheart.00959.20117
Bettendorf M, Schmidt KG, Grulich-Henn J et al (2000) Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356:529–534. https://doi.org/10.1016/s0140-6736(00)02576-9
doi: 10.1016/s0140-6736(00)02576-9
Chowdhury D, Ojamaa K, Parnell VA et al (2001) A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 122:1023–1025. https://doi.org/10.1067/mtc.2001.1161929
doi: 10.1067/mtc.2001.1161929
Mackie AS, Booth KL, Newburger JW et al (2005) A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 130:810–816. https://doi.org/10.1016/j.jtcvs.2005.04.02510
doi: 10.1016/j.jtcvs.2005.04.02510
Marwali EM, Boom CE, Budiwardhana N et al (2017) Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass. Ann Thorac Surg 104:688–695. https://doi.org/10.1016/j.athoracsur.2017.01.00111
doi: 10.1016/j.athoracsur.2017.01.00111
Portman MA, Fearneyhough C, Ning X-H et al (2000) Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 120:604–608. https://doi.org/10.1067/mtc.2000.10890012
doi: 10.1067/mtc.2000.10890012
Talwar S, Bhoje A, Khadagawat R et al (2018) Oral thyroxin supplementation in infants undergoing cardiac surgery: A double-blind placebo-controlled randomized clinical trial. J Thorac Cardiovasc Surg 156:1209-1217.e3. https://doi.org/10.1016/j.jtcvs.2018.05.04413
doi: 10.1016/j.jtcvs.2018.05.04413
Kumar A, Tiwari N, Ramamurthy HR et al (2021) A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases. Ann Pediatric Cardiol 14:170–177. https://doi.org/10.4103/apc.apc_193_2014
doi: 10.4103/apc.apc_193_2014
Portman MA, Slee A, Olson AK et al (2010) Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC). Circulation 122:S224–S233. https://doi.org/10.1161/circulationaha.109.92639415
doi: 10.1161/circulationaha.109.92639415
Portman MA, Slee AE, Roth SJ et al (2022) Triiodothyronine Supplementation in Infants Undergoing Cardiopulmonary Bypass: A Randomized Controlled Trial. Seminars Thorac Cardiovasc Surg. https://doi.org/10.1053/j.semtcvs.2022.01.00516
doi: 10.1053/j.semtcvs.2022.01.00516
Marwali EM, Boom CE, Sakidjan I et al (2013) Oral Triiodothyronine Normalizes Triiodothyronine Levels After Surgery for Pediatric Congenital Heart Disease&ast. Pediatr Crit Care Med 14:701–708. https://doi.org/10.1097/pcc.0b013e3182917f8717
doi: 10.1097/pcc.0b013e3182917f8717
Marwali EM, Lopolisa A, Sani AA et al (2022) Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary Bypass. Pediatr Cardiol 43:726–734. https://doi.org/10.1007/s00246-021-02779-818
doi: 10.1007/s00246-021-02779-818
Tharmapoopathy M, Thavarajah A, Kenny RPW et al (2022) Efficacy and Safety of Triiodothyronine Treatment in Cardiac Surgery or Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Thyroid. https://doi.org/10.1089/thy.2021.060919
doi: 10.1089/thy.2021.060919
Flores S, Loomba RS, Checchia PA et al (2020) Thyroid Hormone (Triiodothyronine) Therapy in Children After Congenital Heart Surgery: A Meta-Analysis. Seminars Thorac Cardiovasc Surg 32:87–95. https://doi.org/10.1053/j.semtcvs.2019.05.02020
doi: 10.1053/j.semtcvs.2019.05.02020
Jenkins KJ, Gauvreau K, Newburger JW et al (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118. https://doi.org/10.1067/mtc.2002.11906421
doi: 10.1067/mtc.2002.11906421
Cantinotti M, Lorenzoni V, Storti S et al (2013) Thyroid and Brain Natriuretic Peptide Response in Children Undergoing Cardiac Surgery for Congenital Heart Disease: – Age-Related Variations and Prognostic Value –. Circ J 77:188–197. https://doi.org/10.1253/circj.cj-12-083422
doi: 10.1253/circj.cj-12-083422
Kaptein EM, Beale E, Chan LS (2009) Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metabolism 94:3663–3675. https://doi.org/10.1210/jc.2009-0899
doi: 10.1210/jc.2009-0899
Peeters RP (2007) Non thyroidal illness: to treat or not to treat? Ann D’endocrinologie 68:224–228. https://doi.org/10.1016/j.ando.2007.06.01124
doi: 10.1016/j.ando.2007.06.01124
Groot LJD (2006) Non-Thyroidal Illness Syndrome is a Manifestation of Hypothalamic-Pituitary Dysfunction, and in View of Current Evidence, Should be Treated with Appropriate Replacement Therapies. Crit Care Clin 22:57–86. https://doi.org/10.1016/j.ccc.2005.10.00125
doi: 10.1016/j.ccc.2005.10.00125
Jonklaas J, Bianco AC, Bauer AJ et al (2014) Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24:1670–1751. https://doi.org/10.1089/thy.2014.002826
doi: 10.1089/thy.2014.002826
Radman M, Portman M (2016) Thyroid Hormone in the Pediatric Intensive Care Unit. J Pediatr Intensiv Care 05:154–161. https://doi.org/10.1055/s-0036-158328027
doi: 10.1055/s-0036-158328027
Huang SA, Bianco AC (2008) Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pr Endocrinol Metab 4:148–155. https://doi.org/10.1038/ncpendmet072728
doi: 10.1038/ncpendmet072728
Heinle JS, Diaz LK, Fox LS, Tex F, the CCMC Fort Worth, (1997) Early extubation after cardiac operations in neonates and young infants. J Thorac Cardiovasc Surg 114:413–418. https://doi.org/10.1016/s0022-5223(97)70187-929
doi: 10.1016/s0022-5223(97)70187-929
Morales DLS, Carberry KE, Heinle JS et al (2008) Extubation in the Operating Room After Fontan’s Procedure: Effect on Practice and Outcomes. Ann Thorac Surg 86:576–582. https://doi.org/10.1016/j.athoracsur.2008.02.01030
doi: 10.1016/j.athoracsur.2008.02.01030
Chang R-KR, Chen AY, Klitzner TS (2000) Factors Associated With Age at Operation for Children With Congenital Heart Disease. Pediatrics 105:1073–1081. https://doi.org/10.1542/peds.105.5.107331
doi: 10.1542/peds.105.5.107331
Marwali EM, Kekalih A, Yuliarto S et al (2022) Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity. Bmj Paediatr Open 6:e001657. https://doi.org/10.1136/bmjpo-2022-00165732
doi: 10.1136/bmjpo-2022-00165732
Marwali EM, Kekalih A, Haas NA (2012) The effect of malnutrition on T3 levels in pediatric patients undergoing congenital heart surgery. Critics Care & Shock 15:103–110
Ross FJ, Radman M, Jacobs ML et al (2020) Associations between anthropometric indices and outcomes of congenital heart operations in infants and young children: An analysis of data from the Society of Thoracic Surgeons Database. Am Hear J 224:85–97. https://doi.org/10.1016/j.ahj.2020.03.01234
doi: 10.1016/j.ahj.2020.03.01234
Ross F, Latham G, Joffe D et al (2017) Preoperative malnutrition is associated with increased mortality and adverse outcomes after paediatric cardiac surgery. Cardiol Young 27:1716–1725. https://doi.org/10.1017/s104795111700106835
doi: 10.1017/s104795111700106835
Radman M, Mack R, Barnoya J et al (2014) The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR). J Thorac Cardiovasc Surg 147:442–450. https://doi.org/10.1016/j.jtcvs.2013.03.02336
doi: 10.1016/j.jtcvs.2013.03.02336
Zimmermann-Belsing T, Brabant G, Holst J, Feldt-Rasmussen U (2003) Circulating leptin and thyroid dysfunction. Eur J Endocrinol 149:257–271. https://doi.org/10.1530/eje.0.149025737
doi: 10.1530/eje.0.149025737
Warner MH, Beckett GJ (2010) Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 205:1–13. https://doi.org/10.1677/joe-09-041238
doi: 10.1677/joe-09-041238
Mebis L, van den Berghe G (2009) The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med 67:332–340